Immune dysfunction and immunomodulation following traumaANTONACCI, A. C.Advances in host defense mechanisms. 1986, Vol 6, pp 81-109, issn 0732-0566Article

Aktuelle Therapie: immunopharmaka = Traitement actuel: immunomédicaments = New trends in therapy: immunopharmacologyMAHRLE, G.H + G. Zeitschrift für Hautkrankheiten. 1987, Vol 62, Num 10, pp 753-765, issn 0301-0481, 9 p.Article

Cyclosporin A: immune suppressant and antiparasitic agentTHOMSON, A. W; SMITH, S. W. G; CHAPPELL, L. H et al.Parasitology today (Regular ed.). 1986, Vol 2, Num 10, pp 288-290, issn 0169-4758Article

Binding of human alpha-interferons to natural killer cellsLANGER, J. A; ORTALDO, J. R; PESTKA, S et al.Journal of interferon research. 1986, Vol 6, Num 2, pp 97-105, issn 0197-8357Article

Cyclosporin a treatment of refractory rheumatoid arthritisWEINBLATT, M. E; COBLYN, J. S; FRASER, P. A et al.Arthritis and rheumatism. 1987, Vol 30, Num 1, pp 11-17, issn 0004-3591Article

Effect of phenytoin on antibody production: use of a murine modelMARGARETTEN, N. C; WARREN, R. P.Epilepsia (Copenhagen). 1987, Vol 28, Num 1, pp 77-80, issn 0013-9580Article

Alteration of some leukocyte functions following in vivo and in vitro exposure to recombinant bovine alpha- and gamma-interferonOHMANN, H. B; BABIUK, L. A.Journal of interferon research. 1986, Vol 6, Num 2, pp 123-136, issn 0197-8357Article

Inhibition of antibody production by 2-chloroadenosineSAMET, M. K.Life sciences (1973). 1985, Vol 37, Num 3, pp 225-233, issn 0024-3205Article

Le point sur la radiosensibilité des lymphocytes: les possibles incidences thérapeutiques = The position about lymphocyte radiosensibility: therapeutic potential incidencePAULE, B; COSSET, J. M.Biomedicine & pharmacotherapy. 1985, Vol 39, Num 9-10, pp 467-472, issn 0753-3322Article

Inhibition of drug-induced eosinophilia by cyclosporin ATHOMSON, A. W; MILTON, J. I; ALDRIDGE, R. D et al.Scandinavian journal of immunology (Print). 1986, Vol 24, Num 2, pp 163-170, issn 0300-9475Article

Perioperative blood transfusion and cancer prognosis: different effects of blood transfusion on prognosis of colon and breast cancer patientsVOOGT, P. J; VAN DE VELDE, C. J. H; BRAND, A et al.Cancer. 1987, Vol 59, Num 4, pp 836-843, issn 0008-543XArticle

The lymphatic route. I: Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasmaBOCCI, V; MUSCETTOLA, M; GRASSO, G et al.Experientia. 1986, Vol 42, Num 4, pp 432-433, issn 0014-4754Article

Desferoxamine blocks IL 2 receptor expression on human T lymphocytesCAROTENUTO, P; PONTESILLI, O; CAMBIER, J. C et al.The Journal of immunology (1950). 1986, Vol 136, Num 7, pp 2342-2347, issn 0022-1767Article

Immunopotentiating activities of cell walls, peptidoglycans, and teichoic acids from two strains of Listeria monocytogenesPAQUET, A. JR; RAINES, K. M; BROWNBACK, P. C et al.Infection and immunity. 1986, Vol 54, Num 1, pp 170-176, issn 0019-9567Article

Eruptions au cours des renversements immunologiques chez des lépromateux traités par des immunomodulants = Eruptions during immunological disturbances in lepromatous leprosy treated with immunomodulatorsSAINT-ANDRE, P; BAQUILLON, G.Acta leprologica. 1986, Num 101, pp 201-203, issn 0001-5938Conference Paper

Effects of anti-tuberculosis drugs on the production of prostaglandin E₂ and on mononuclear leucocyte transformationZEIS, B. M.Chemotherapy (Basel). 1987, Vol 33, Num 3, pp 204-210, issn 0009-3157Article

Neurobiology and cancer: possible role of β-endorphins in cancer growth regulationLE GOASTER, J; LE MAGNEN, J.Cancer journal (Villejuif). 1987, Vol 1, Num 5, pp 204-207Article

Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functionsEL-HAG, A; LIPSKY, P. E; BENNETT, M et al.The Journal of immunology (1950). 1986, Vol 136, Num 9, pp 3420-3426, issn 0022-1767Article

Growth factors, oncogenes, and interferonsFRIEDMAN, R. M.Journal of experimental pathology. 1986, Vol 2, Num 4, pp 223-228, issn 0730-8485Article

Immunomodulation by bronchial lavage cells in normal individuals and patients with bronchogenic carcinomaWEISSMAN, D. N; DE SHAZO, R. D; BANKS, D. E et al.The American journal of the medical sciences. 1986, Vol 292, Num 4, pp 187-192, issn 0002-9629Article

Interferon therapy in cancer: from imaginon to interferonGOLDSTEIN, D; LASZLO, J.Cancer research (Baltimore). 1986, Vol 46, Num 9, pp 4315-4329, issn 0008-5472Article

Kinetics of prostaglandin E₂ and thromboxane A₂ synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytesAWARA, W; HILLIER, K; JONES, D et al.Immunology (Oxford). 1986, Vol 59, Num 4, pp 557-562, issn 0019-2805Article

Differential effects of intact subunits and nicked fragments of concanavalin A on immune functions in vitro and in vivoGRISWOLD, D. E; BADGER, A. M; BENDER, P. E et al.The Journal of immunology (1950). 1983, Vol 131, Num 4, pp 1626-1628, issn 0022-1767Article

Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimideBERRY, J; GREEN, B. J; MATHESON, D. S et al.Cancer immunology and immunotherapy. 1987, Vol 24, Num 1, pp 72-75, issn 0340-7004Article

Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challengeDUNN, P. L; JOHNSON, C. A; STYLES, J. M et al.Immunology (Oxford). 1987, Vol 60, Num 2, pp 181-186, issn 0019-2805Article